Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.93 - $18.45 $50.1 Million - $71.5 Million
3,877,112 New
3,877,112 $55.9 Million
Q4 2023

Feb 09, 2024

BUY
$8.6 - $14.94 $36.1 Million - $62.7 Million
4,195,311 New
4,195,311 $62.5 Million
Q3 2023

Nov 13, 2024

BUY
$9.81 - $12.62 $41.6 Million - $53.6 Million
4,244,570 New
4,244,570 $47.7 Million
Q3 2023

Nov 13, 2023

SELL
$9.81 - $12.62 $65.6 Million - $84.4 Million
-6,689,100 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$8.08 - $10.37 $2.82 Million - $3.62 Million
349,052 Added 9.0%
4,226,164 $42.5 Million
Q2 2023

Aug 14, 2023

SELL
$8.08 - $10.37 $40.9 Million - $52.5 Million
-5,060,954 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$8.79 - $14.58 $37.2 Million - $61.7 Million
4,228,400 New
4,228,400 $39.7 Million
Q4 2022

Feb 14, 2023

BUY
$11.49 - $13.65 $77.4 Million - $91.9 Million
6,735,598 New
6,735,598 $82.3 Million
Q3 2022

Nov 13, 2023

BUY
$12.41 - $32.42 $83 Million - $217 Million
6,689,100 New
6,689,100 $83 Million
Q2 2022

Aug 14, 2023

BUY
$19.63 - $26.62 $99.3 Million - $135 Million
5,060,954 New
5,060,954 $99.3 Million
Q1 2022

May 12, 2023

SELL
$24.65 - $29.0 $50.7 Million - $59.6 Million
-2,055,346 Reduced 30.51%
4,680,252 $122 Million
Q1 2022

May 09, 2022

SELL
$24.65 - $29.0 $105 Million - $123 Million
-4,250,857 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$27.74 - $34.09 $118 Million - $145 Million
4,250,857 New
4,250,857 $121 Million
Q3 2021

Nov 14, 2022

BUY
$29.2 - $36.72 $127 Million - $159 Million
4,341,574 New
4,341,574 $138 Million
Q3 2021

Nov 05, 2021

SELL
$29.2 - $36.72 $144 Million - $181 Million
-4,932,630 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$28.76 - $35.98 $142 Million - $177 Million
4,932,630 New
4,932,630 $171 Million
Q2 2021

Aug 10, 2021

SELL
$28.76 - $35.98 $143 Million - $179 Million
-4,970,041 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$27.85 - $34.49 $138 Million - $171 Million
4,970,041 New
4,970,041 $146 Million
Q1 2021

May 07, 2021

SELL
$27.85 - $34.49 $242 Million - $299 Million
-8,675,445 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$27.53 - $33.79 $239 Million - $293 Million
8,675,445 New
8,675,445 $266 Million
Q4 2020

Feb 10, 2021

SELL
$27.53 - $33.79 $102 Million - $125 Million
-3,687,182 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$21.1 - $29.13 $77.8 Million - $107 Million
3,687,182 New
3,687,182 $103 Million
Q3 2020

Nov 10, 2020

SELL
$21.1 - $29.13 $83.9 Million - $116 Million
-3,974,052 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$18.94 - $24.93 $75.3 Million - $99.1 Million
3,974,052 New
3,974,052 $85.2 Million
Q2 2020

Aug 07, 2020

SELL
$18.94 - $24.93 $77.2 Million - $102 Million
-4,076,671 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$16.68 - $32.25 $68 Million - $131 Million
4,076,671 New
4,076,671 $91.3 Million
Q1 2020

May 08, 2020

SELL
$16.68 - $32.25 $66.2 Million - $128 Million
-3,966,936 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$25.29 - $29.45 $100 Million - $117 Million
3,966,936 New
3,966,936 $117 Million
Q4 2019

Feb 12, 2020

SELL
$25.29 - $29.45 $96.8 Million - $113 Million
-3,827,594 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$25.62 - $34.96 $98.1 Million - $134 Million
3,827,594 New
3,827,594 $102 Million
Q3 2019

Nov 08, 2019

SELL
$25.62 - $34.96 $96.4 Million - $131 Million
-3,761,194 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$31.11 - $34.79 $117 Million - $131 Million
3,761,194 New
3,761,194 $127 Million
Q2 2019

Aug 09, 2019

SELL
$31.11 - $34.79 $109 Million - $122 Million
-3,512,926 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$29.0 - $32.83 $46.2 Million - $52.3 Million
1,593,286 Added 83.0%
3,512,926 $113 Million
Q4 2018

Mar 04, 2019

BUY
$29.63 - $34.5 $56.9 Million - $66.2 Million
1,919,640 New
1,919,640 $60.5 Million
Q4 2018

Feb 08, 2019

SELL
$29.63 - $34.5 $45 Million - $52.4 Million
-1,520,000 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$34.1 - $36.19 $51.8 Million - $55 Million
1,520,000 New
1,520,000 $53 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.